22301/34347US=39 / Câncer
Bonavida B, Huerta-Yepez S, Vega MI, Spandidos DA, Baritaki S. Nitric oxide-induced immunosensitization to apoptosis by Fas-L and TRAIL. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 203-10. ISBN 978-1-58829-989-5.

IMMUNOSENSIBILIZACAO; OXIDO NITRICO; APOPTOSE; FAS-L; TRAIL


22302/34347US=39 / Câncer
Jagetia G, Krishnan S, Aggarwal BB. Natural agents that can sensitize tumor cells to chemotherapy and radiation therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 211-40. ISBN 978-1-58829-989-5.

SENSIBILIZACAO DE CELULAS TUMORAIS; AGENTES NATURAIS; QUIMIOTERAPIA; TERAPIA POR RADIACAO; QUIMIORRESISTENCIA; RADIORESISTENCIA; POLIFENOIS RADIOSENSIVEIS


22303/34347US=39 / Câncer
Johnson DE. Inhibitors of the Bcl-2 protein family as sensitizers to anticancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 243-61. ISBN 978-1-58829-989-5.

INIBIDORES BCL-2; AGENTES ANTICANCERIGENOS; APOPTOSE; PEPTIDEOS BH3


22304/34347US=39 / Câncer
Wilson TR, Longley DB, Johnston PG. Therapeutic targeting of apoptosis in cancer. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 263-78. ISBN 978-1-58829-989-5.

APOPTOSE NO CANCRO; SEGMENTACAO TERAPEUTICA


22305/34347US=39 / Câncer
Banerji S, Ande SR, Maddika S, Banerji V, Rashedi I, Owens NW, Zuse A, Schweizer F, Los M. Peptides and peptidomimetics as cancer therapy sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 279-303. ISBN 978-1-58829-989-5.

PEPTIDOS; PEPTIDOMIMETICOS; AGENTES SENSIBILIZANTES; TERAPIA DO CANCRO


22306/34347US=39 / Câncer
Dings RPM, Klein M, Mayo KH. Non-peptidic mimetics as cancer-sensitizing agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 305-25. ISBN 978-1-58829-989-5.

AGENTES SENSIBILIZADORES NAO-PEPTIDICOS MIMETICOS; CANCER; TERAPEUTICA DE COMBINACAO


22307/34347US=39 / Câncer
Sarkar FH, Li Y. Sensitization of cancer cells to cancer therapies by isoflavone and its synthetic derivatives. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 327-35. ISBN 978-1-58829-989-5.

SENSIBILIZACAO DAS CELULAS CANCEROSAS; TERAPIA DO CANCER; ISOFLAVONA; DERIVADOS SINTETICOS


22308/34347US=39 / Câncer
Förster Y, Schwenzer B. Antisense oligonucleotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potential. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 337-62. ISBN 978-1-58829-989-5.

OLIGONUCLEOTIDOS ANTI-SENTIDO; SIRNA COMO INIBIDORES ESPECIFICOS; EXPRESSAO DO GENE; MECANISMOS DE ACAO; POTENCIAL TERAPEUTICO


22309/34347US=39 / Câncer
Efferth T, Wink M. DNA polymorphisms affecting chemosensitivity toward drugs. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 365-87. ISBN 978-1-58829-989-5.

POLIMORFISMOS DE DNA; QUIMIOSENSIBILIDADE; DEFICIENCIA EM GLICOSE-6-FOSFATO DESIDROGENASE; CANCER


22310/34347US=39 / Câncer
Cecchin E, Libra M, Cannavò C, Bruni B, Fulvi A, Toffoli G, Stivala F. Pharmacogenetics in cancer management: scenario for tailored therapy. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 389-403. ISBN 978-1-58829-989-5.

CANCER. TERAPIA; FARMACOGENETICA; METABOLISMO DE FARMACOS; TRANSPORTE DE FARMACOS; MECANISMO DE ACAO DOS FARMACOS


22311/34347US=30 / Clín/Medica
Rácz ML, Candeias JAN. Hepatites virais. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 645-56. ISBN 85-7379981-1.

VIRUS; HEPATITE A; HEPATITE B; HEPATITE C; HEPATITE D; HEPATITE E


22312/34347US=30 / Clín/Medica
Rácz ML. Ortomixovírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 657-61. ISBN 85-7379981-1.

VIRUS; ORTOMIXOVIRUS; PROPRIEDADES; PATOGENESE; EPIDEMIOLOGIA; DIAGNOSTICO LABORATORIAL; TRATAMENTO


22313/34347US=30 / Clín/Medica
Rácz ML. Papilomavírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 663-5. ISBN 85-7379981-1.

VIRUS; PAPILOMAVIRUS; PROPRIEDADES; PATOGENESE; EPIDEMIOLOGIA; DIAGNOSTICO LABORATORIAL; TRATAMENTO; PREVENCAO; CONTROLE


22314/34347US=30 / Clín/Medica
Rácz ML. Paramixovírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 667-74. ISBN 85-7379981-1.

VIRUS; PARAMIXOVIRUS; SARAMPO; VIRUS PARAINFLUENZA; VIRUS RESPIRATORIO SINCICIAL; METAPNEUMOVIRUS HUMANO; CAXUMBA; VIRUS HENDRA; VIRUS NIPAH; PROPRIEDADES; PATOGENESE; EPIDEMIOLOGIA; DIAGNOSTICO LABORATORIAL; TRATAMENTO; PREVENCAO; CONTROLE


22315/34347US=30 / Clín/Medica
Rácz ML. Parvovírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 675-7. ISBN 85-7379981-1.

VIRUS; PARVOVIRUS; PROPRIEDADES; PATOGENESE; EPIDEMIOLOGIA; DIAGNOSTICO LABORATORIAL; TRATAMENTO; PREVENCAO; CONTROLE


22316/34347US=30 / Clín/Medica
Rácz ML. Picornavírus. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 679-84. ISBN 85-7379981-1.

VIRUS; PICORNAVIRUS; POLIOMELITE; ENTEROVIRUS; RINOVIRUS; PROPRIEDADES; PATOGENESE; EPIDEMIOLOGIA; DIAGNOSTICO LABORATORIAL; TRATAMENTO; PREVENCAO; CONTROLE


22317/34347US=18 / Pediatria
Donaldson SS. Introduction and historical background: pediatric hodgkin lymphoma. In: Weinstein HJ, Hudson MM, Link MP. Pediatric lymphomas. New York: Springer Verlag, 2008. p. 1-5. (Pediatric Oncology) ISBN 978-3-540-20356-8.

PEDIATRICA LINFOMA DE HODGKIN; LICOES DOS FILHOS


22318/34347US=18 / Pediatria
Huntchison RE, Uner A. Biology and pathology of Hodgkin's Disease. In: Weinstein HJ, Hudson MM, Link MP. Pediatric lymphomas. New York: Springer Verlag, 2008. p. 7-33. (Pediatric Oncology) ISBN 978-3-540-20356-8.

DOENCA DE HODGKIN; DE NECROSE TUMORAL DA FAMILIA DO RECEPTOR DO FACTOR; CITOCINAS; QUIMIOCINAS; CITOGENETICA; PERFIL GENETICO; LINFOMA DE HODGKIN CLASSICO; LINFOCITOS NODULAR; LINFOCITOS EMPOBRECIDO; NODULAR LINFOCITO LINFOMA DE HODGKIN PREDOMINANTE


22319/34347US=18 / Pediatria
Hudson MM, Schwartz C, Constine LS. Treatment of pediatric Hodgkin lymphoma. In: Weinstein HJ, Hudson MM, Link MP. Pediatric lymphomas. New York: Springer Verlag, 2008. p. 35-66. (Pediatric Oncology) ISBN 978-3-540-20356-8.

TRATAMENTO DO LINFOMA DE HODGKIN PEDIATRICO; QUIMIOTERAPIA; TRATAMENTO DO RISCO DE DOENCA; TERAPIA DE RADIACAO


22320/34347US=18 / Pediatria
Trippett TM, Chen A. Treatment of relapsed/refractory hodgkin lymphoma. In: Weinstein HJ, Hudson MM, Link MP. Pediatric lymphomas. New York: Springer Verlag, 2008. p. 67-84. (Pediatric Oncology) ISBN 978-3-540-20356-8.

TRATAMENTO DE LINFOMA DE HODGKIN; REFRATARIO


Primeira | Anterior | Próxima | Última